Previous Article | Next Article ![]()
Infection and Immunity, March 2004, p. 1397-1401, Vol. 72, No. 3
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.3.1397-1401.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Institut de Parasitologie et de Pathologie Tropicale, INSERM U392, 67000 Strasbourg, France
Received 23 September 2003/ Returned for modification 10 November 2003/ Accepted 9 December 2003
Protective immunity in mice infected with Toxoplasma gondii is mainly mediated by NK cells, CD4 and CD8 T cells, and type 1 cytokines, such as gamma interferon (IFN-
). To clarify the roles of NK cells and IFN-
in protection against primary congenital toxoplasmosis, we used recombination activating gene 2 knockout (RAG-2-/-) mice, which lack T and B lymphocytes, in comparison with the wild-type BALB/c model. RAG-2-/- mice had a significantly lower risk of fetal toxoplasmosis than BALB/c mice (25 versus 63.9%; P = 0.003). This protection was associated with an increased number of maternal NK cells, IFN-
secretion by spleen cells, and decreased parasitemia. In the RAG-2-/- mice, NK cell depletion increased both the rate of fetal infection, to 56.5% (P = 0.02), and the blood parasite burden. Conversely, in the BALB/c mice, this treatment did not modify maternofetal transmission or the blood parasite burden. Neutralization of IFN-
in both infected RAG-2-/- and BALB/c mice decreased congenital Toxoplasma transmission, contrasting with an exacerbation of maternal infection. These data suggest that a partially protective immunity against congenital toxoplasmosis is achieved due to the increased number of NK cells in RAG-2-/- mice. However, it seems that IFN-
enhances, directly or indirectly, the transplacental transmission.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|